01 7Vasostrict
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 786
2019 Revenue in Millions : 532
Growth (%) : 48
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 902
2020 Revenue in Millions : 786
Growth (%) : 15
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 254
2021 Revenue in Millions : 902
Growth (%) : -72
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 93
2022 Revenue in Millions : 254
Growth (%) : -63
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2024 Revenue in Millions : 36
2023 Revenue in Millions : 93
Growth (%) : -61
Main Therapeutic Indication : Renal Disorders
Currency : USD
2018 Revenue in Millions : 454
2017 Revenue in Millions : 400
Growth (%) : 14%
Main Therapeutic Indication : Nephrology
Currency : USD
2019 Revenue in Millions : 532
2018 Revenue in Millions : 454
Growth (%) : 17
